Market Research

NA Melanoma Cancer Diagnostics Market - Industry Trends and Forecast to 2030

Best Price Guarantee Length Publisher Published Date SKU
from $3,500 193 Pages Data Bridge Market Research November, 2022 DAABD17583267
Best Price Guarantee
Price from $3,500
Length 193 Pages
Publisher Data Bridge Market Research
Published Date November, 2022
SKU DAABD17583267

NA Melanoma Cancer Diagnostics Market - Industry Trends and Forecast to 2030

The North America melanoma cancer diagnostics market is projected to register a substantial CAGR of 7.4% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.

Market Segmentation

North America Melanoma Cancer Diagnostics Market, By Product Type (Instruments, Consumables and Accessories, and Others), Test Type (Biomarkers Test, Imaging Test, Biopsy, Fluorescent In Situ Hybridization (FISH) Tests, Comparative Genomic Hybridization (CGH) tests, Immunohistochemical (IHC) tests, and Others), End User (Hospitals, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes and Others), Distribution channel (Direct Tender and Retail Sales), Country (U.S., Canada, Mexico) Industry Trends and Forecast 2030

Some of the major factors contributing to the growth of the North America melanoma cancer diagnostics market are:

• Increase in demand for early melanoma diagnosis
• Rising preference for preventive health check-ups

Market Players

Some of the major players operating in the North America melanoma cancer diagnostics market are:

• NanoString
• Thermo Fisher Scientific Inc.
• Quest Diagnostics Incorporated
• Agilent Technologies, Inc.
• QIAGEN
• Inivata Ltd.
• F. Hoffman-La Roche Ltd
• Abbott
• Myriad Genetics, Inc.
• Castle Biosciences
• DermTech
• Michael Diagnostics Ltd
• DermLite
• DermaSensor
• Skyline Dx
• VERISKIN INC.
• Illumina Inc
• bioMerieux SA

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.


1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of The North America Melanoma Cancer Diagnostics Market
1.4 Limitations
1.5 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Dbmr Tripod Data Validation Model
2.6 Multivariate Modelling
2.7 Product Type Lifeline Curve
2.8 Primary Interviews With Key Opinion Leaders
2.9 Dbmr Market Position Grid
2.10 Market End User Coverage Grid
2.11 Vendor Share Analysis
2.12 Secondary Sources
2.13 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Pestel's Model
4.2 Porter's Five Forces Model
5 Epidemiology
6 Industry Insights
6.1 Demographic Trends
6.2 Key Pricing Strategies
6.2.1 Product Innovation
6.2.2 Consumer Awarness
6.2.3 A Vast Network Of Distribution
6.2.4 Partnership With Popular Brands By Major Players
6.2.5 Others
6.3 Key Patient Enrollment Strategies
6.3.1 Identification Of Customers Need For Innovative Diagostic Products
6.3.2 Increasing Specific Tactics For Every Step
6.3.3 Educate And Communicate
6.3.4 Improving Diagnosis Seeking Rate
6.4 Interviews With Manufacturing Companies
7 Market Overview
7.1 Drivers
7.1.1 Growing Prevalence Of Melanoma Cancer
7.1.2 Rising Preference For Preventive Health Check-ups
7.1.3 Novel Technologies In Melanoma Cancer Diagnostics
7.1.4 Increasing Awareness Regarding Melanoma Cancer
7.2 Restraints
7.2.1 Lack Of Skilled And Certified Professionals
7.2.2 High Cost Of Diagnostics Procedure For Melanoma Cancers
7.3 Opportunities
7.3.1 Increasing Healthcare Expenditure For Melanoma Cancer Treatment
7.3.2 Government Initiatives Toward Melanoma Cancer Diagnostics
7.3.3 Increased Demand For Non-invasive Testing Methods
7.3.4 Growing Demand For Better Quality Healthcare
7.4 Challenges
7.4.1 Strict Regulations And Standards For The Approval And Commercialization Of Melanoma Cancer Diagnostic Products
7.4.2 Radiation Risks From Imaging Tests
8 North America Melanoma Cancer Diagnostics Market, By Product Type
8.1 Overview
8.2 Instruments
8.2.1 Imaging Instruments
8.2.1.1 Ultrasound Systems
8.2.1.2 Mri Systems
8.2.1.3 Ct Systems
8.2.1.4 Others
8.2.2 Biopsy Instruments
8.2.3 Pathology-based Instruments
8.2.3.1 Pcr Instruments
8.2.3.2 Cell Processors
8.2.3.3 Slide Staining Systems
8.2.3.4 Tissue Processing Systems
8.2.3.5 Other Pathology-based Instruments
8.3 Consumables & Accessories
8.3.1 Kits
8.3.1.1 Pcr Kits
8.3.1.2 Nucleic Acid Isolation Kits
8.3.1.3 Dna Polymerase Kits
8.3.1.4 Others
8.3.2 Probes
8.3.2.1 Q Fish
8.3.2.2 Flow Fish
8.3.2.3 Others
8.3.3 Reagents
8.3.3.1 Assays
8.3.3.2 Buffers
8.3.3.3 Primers
8.3.3.4 Others
8.3.4 Other Consumables
8.4 Others
9 North America Melanoma Cancer Diagnostics Market, By Test Type
9.1 Overview
9.2 Imaging Test
9.2.1 Ultrasound
9.2.2 Mri
9.2.3 Chest X-ray
9.2.4 Lymphoscintigraphy
9.2.5 Computed Tomography (Ct) Scan
9.2.6 Positron Emission Tomography (Pet) Scan
9.2.7 Others
9.3 Biopsy
9.3.1 Optical Biopsy
9.3.2 Excisional Biopsy
9.3.3 Incisional Biopsy
9.3.4 Shave Biopsy
9.3.5 Punch Biopsy
9.3.6 Others
9.4 Immunohistochemical (Ihc) Tests
9.4.1 S100 Protein Family Biopsy
9.4.2 Melan-a
9.4.3 Pmel/Pmel17/Silv/Gp100
9.4.4 Tyrosinase
9.4.5 Mitf
9.4.6 Sm5-1
9.4.7 Cspg4/Hmw-maa
9.5 Biomarker Test
9.5.1 Braf Mutation Test
9.5.2 Nras Mutation Test
9.5.3 Ckit Test
9.5.4 Others
9.6 Fluorescent In Situ Hybridization (Fish) Tests
9.7 Comparative Genomic Hybridization (Cgh) Tests
9.8 Others
10 North America Melanoma Cancer Diagnostics Market, By End User
10.1 Overview
10.2 Hospitals
10.3 Associated Labs
10.4 Diagnostic Imaging Centers
10.5 Independent Diagnostic Laboratories
10.6 Cancer Research Institutes
10.7 Others
11 North America Melanoma Cancer Diagnostics Market, By Distribution Channel
11.1 Overview
11.2 Direct Tender
11.3 Retail Sales
12 North America Melanoma Cancer Diagnostics Market, By Region
12.1 North America
12.1.1 U.S.
12.1.2 Canada
12.1.3 Mexico
13 North America Melanoma Cancer Diagnostics Market, Company Landscape
13.1 Company Share Analysis: North America
14 Swot Analysis
15 Company Profile
15.1 Abbott
15.1.1 Company Snapshot
15.1.2 Revenue Analysis
15.1.3 Company Share Analysis
15.1.4 Product Portfolio
15.1.5 Recent Developments
15.2 Illumina, Inc.
15.2.1 Company Snapshot
15.2.2 Revenue Analysis
15.2.3 Company Share Analysis
15.2.4 Product Portfolio
15.2.5 Recent Development
15.3 Biomérieux Sa
15.3.1 Company Snapshot
15.3.2 Revenue Analysis
15.3.3 Company Share Analysis
15.3.4 Product Portfolio
15.3.5 Recent Developments
15.4 Thermo Fisher Scientific Inc.
15.4.1 Company Snapshot
15.4.2 Revenue Analysis
15.4.3 Company Share Analysis
15.4.4 Product Portfolio
15.4.5 Recent Development
15.5 F. Hoffmann-la Roche Ltd.
15.5.1 Company Snapshot
15.5.2 Revenue Analysis
15.5.3 Company Share Analysis
15.5.4 Product Portfolio
15.5.5 Recent Development
15.6 Agilent Technologies, Inc.
15.6.1 Company Profile
15.6.2 Revenue Analysis
15.6.3 Product Portfolio
15.6.4 Recent Development
15.7 Amlo Biosciences Limited
15.7.1 Company Profile
15.7.2 Product Portfolio
15.7.3 Recent Development
15.8 Castle Biosciences Inc
15.8.1 Company Snapshot
15.8.2 Revenue Analysis
15.8.3 Product Portfolio
15.8.4 Recent Development
15.9 Damae Medical
15.9.1 Company Profile
15.9.2 Product Portfolio
15.9.3 Recent Development
15.10 Dermlite.
15.10.1 Company Profile
15.10.2 Product Portfolio
15.10.3 Recent Developments
15.11 Dermasensor
15.11.1 Company Profile
15.11.2 Product Portfolio
15.11.3 Recent Development
15.12 Dermtech
15.12.1 Company Snapshot
15.12.2 Revenue Analysis
15.12.3 Product Portfolio
15.12.4 Recent Development
15.13 Inivata Ltd.
15.13.1 Company Profile
15.13.2 Product Portfolio
15.13.3 Recent Development
15.14 Michael Diagnostics Ltd
15.14.1 Company Snapshot
15.14.2 Product Portfolio
15.14.3 Recent Development
15.15 Myriad Genetics, Inc.
15.15.1 Company Snapshot
15.15.2 Revenue Analysis
15.15.3 Product Portfolio
15.15.4 Recent Development
15.16 Nanostring
15.16.1 Company Snapshot
15.16.2 Revenue Analysis
15.16.3 Product Portfolio
15.16.4 Recent Development
15.17 Neracare Gmbh
15.17.1 Company Profile
15.17.2 Product Portfolio
15.17.3 Recent Development
15.18 Skin Analytics
15.18.1 Company Profile
15.18.2 Product Portfolio
15.18.3 Recent Development
15.19 Skylinedx
15.19.1 Company Profile
15.19.2 Product Portfolio
15.19.3 Recent Developments
15.20 Veriskin Inc.
15.20.1 Company Profile
15.20.2 Product Portfolio
15.20.3 Recent Developments
15.21 Qiagen
15.21.1 Company Snapshot
15.21.2 Revenue Analysis
15.21.3 Product Portfolio
15.21.4 Recent Development
15.22 Quest Diagnostics Incorporated (2022)
15.22.1 Company Snapshot
15.22.2 Revenue Analysis
15.22.3 Product Portfolio
15.22.4 Recent Developments
16 Questionnaire
17 Related Reports 193
List Of Tables
Table 1 North America Melanoma Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 2 North America Instruments In Melanoma Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 3 North America Instruments In Melanoma Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 4 North America Imaging Instruments In Melanoma Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 5 North America Pathology-based Instruments In Melanoma Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 6 North America Consumers & Accessories In Melanoma Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 7 North America Consumables & Accessories In Melanoma Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 8 North America Kits In Melanoma Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 9 North America Probes In Melanoma Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 10 North America Reagents In Melanoma Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 11 North America Others In Melanoma Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 12 North America Melanoma Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 13 North America Imaging Test In Melanoma Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 14 North America Imaging Test In Melanoma Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 15 North America Biopsy In Melanoma Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 16 North America Biopsy In Melanoma Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 17 North America Immunohistochemical (Ihc) Tests In Melanoma Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 18 North America Immunohistochemical (Ihc) Tests In Melanoma Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 19 North America Biomarkers Test In Melanoma Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 20 North America Biomarkers Test In Melanoma Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 21 North America Fluorescent In Situ Hybridization (Fish) Tests In Melanoma Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 22 North America Comparative Genomic Hybridization (Cgh) Tests In Melanoma Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 23 North America Others In Melanoma Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 24 North America Melanoma Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 25 North America Hospitals In Melanoma Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 26 North America Associated Labs In Melanoma Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 27 North America Diagnostic Imaging Centers In Melanoma Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 28 North America Independent Diagnostic Laboratories In Melanoma Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 29 North America Cancer Research Institutes In Melanoma Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 30 North America Others In Melanoma Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 31 North America Melanoma Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 32 North America Direct Tender In Melanoma Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 33 North America Retail Sales In Melanoma Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 34 North America Melanoma Cancer Diagnostics Market, By Country, 2021-2030 (Usd Million)
Table 35 North America Melanoma Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 36 North America Instruments In Melanoma Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 37 North America Pathology-based Instruments In Melanoma Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 38 North America Imaging Instruments In Melanoma Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 39 North America Consumables & Accessories In Melanoma Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 40 North America Kits In Melanoma Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 41 North America Reagents In Melanoma Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 42 North America Probes In Melanoma Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 43 North America Melanoma Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 44 North America Biomarkers Test In Melanoma Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 45 North America Imaging Test In Melanoma Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 46 North America Biopsy In Melanoma Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 47 North America Immunohistochemical (Ihc) Tests In Melanoma Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 48 North America Melanoma Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 49 North America Melanoma Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 50 U.S. Melanoma Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 51 U.S. Instruments In Melanoma Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 52 U.S. Pathology-based Instruments In Melanoma Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 53 U.S. Imaging Instruments In Melanoma Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 54 U.S. Consumables & Accessories In Melanoma Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 55 U.S. Kits In Melanoma Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 56 U.S. Reagents In Melanoma Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 57 U.S. Probes In Melanoma Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 58 U.S. Melanoma Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 59 U.S. Biomarkers Test In Melanoma Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 60 U.S. Imaging Test In Melanoma Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 61 U.S. Biopsy In Melanoma Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 62 U.S. Immunohistochemical (Ihc) Tests In Melanoma Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 63 U.S. Melanoma Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 64 U.S. Melanoma Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 65 Canada Melanoma Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 66 Canada Instruments In Melanoma Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 67 Canada Pathology-based Instruments In Melanoma Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 68 Canada Imaging Instruments In Melanoma Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 69 Canada Consumables & Accessories In Melanoma Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 70 Canada Kits In Melanoma Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 71 Canada Reagents In Melanoma Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 72 Canada Probes In Melanoma Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 73 Canada Melanoma Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 74 Canada Biomarkers Test In Melanoma Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 75 Canada Imaging Test In Melanoma Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 76 Canada Biopsy In Melanoma Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 77 Canada Immunohistochemical (Ihc) Tests In Melanoma Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 78 Canada Melanoma Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 79 Canada Melanoma Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 80 Mexico Melanoma Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 81 Mexico Instruments In Melanoma Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 82 Mexico Pathology-based Instruments In Melanoma Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 83 Mexico Imaging Instruments In Melanoma Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 84 Mexico Consumables & Accessories In Melanoma Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 85 Mexico Kits In Melanoma Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 86 Mexico Reagents In Melanoma Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 87 Mexico Probes In Melanoma Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
Table 88 Mexico Melanoma Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 89 Mexico Biomarkers Test In Melanoma Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 90 Mexico Imaging Test In Melanoma Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 91 Mexico Biopsy In Melanoma Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 92 Mexico Immunohistochemical (Ihc) Tests In Melanoma Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 93 Mexico Melanoma Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 94 Mexico Melanoma Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
List Of Figures
Figure 1 North America Melanoma Cancer Diagnostics Market: Segmentation
Figure 2 North America Melanoma Cancer Diagnostics Market: Data Triangulation
Figure 3 North America Melanoma Cancer Diagnostics Market: Droc Analysis
Figure 4 North America Melanoma Cancer Diagnostics Market: North America Vs Regional Market Analysis
Figure 5 North America Melanoma Cancer Diagnostics Market: Company Research Analysis
Figure 6 North America Melanoma Cancer Diagnostics Market: Interview Demographics
Figure 7 North America Melanoma Cancer Diagnostics Market: Dbmr Market Position Grid
Figure 8 North America Melanoma Cancer Diagnostics Market: Market End User Coverage Grid
Figure 9 North America Melanoma Cancer Diagnostics Market: Vendor Share Analysis
Figure 10 North America Melanoma Cancer Diagnostics Market: Segmentation
Figure 11 The Growing Prevalence Of Melanoma Cancer And The Increasing Awareness Regarding Melanoma Cancer Are Expected To Drive The North America Melanoma Cancer Diagnostics Market Growth In The Forecast Period Of 2023 To 2030
Figure 12 Instruments Segment Is Expected To Account For The Largest Share Of The North America Melanoma Cancer Diagnostics Market In 2023 & 2030
Figure 13 Estimated Prevalence Of Melanoma Cancer In 2020
Figure 14 Drivers, Restraints, Opportunities, And Challenges Of The North America Melanoma Cancer Diagnostics Market
Figure 15 Number Of New Cases In 2018 In Females Of All Ages
Figure 16 Ageing Europe Population (In Million)
Figure 17 Estimated Lifetime Care Spending
Figure 18 North America Melanoma Cancer Diagnostics Market: By Product Type, 2022
Figure 19 North America Melanoma Cancer Diagnostics Market: By Product Type, 2023-2030 (Usd Million)
Figure 20 North America Melanoma Cancer Diagnostics Market: By Product Type, Cagr (2023-2030)
Figure 21 North America Melanoma Cancer Diagnostics Market: By Product Type, Lifeline Curve
Figure 22 North America Melanoma Cancer Diagnostics Market: By Test Type, 2022
Figure 23 North America Melanoma Cancer Diagnostics Market: By Test Type, 2023-2030 (Usd Million)
Figure 24 North America Melanoma Cancer Diagnostics Market: By Test Type, Cagr (2023-2030)
Figure 25 North America Melanoma Cancer Diagnostics Market: By Test Type, Lifeline Curve
Figure 26 North America Melanoma Cancer Diagnostics Market: By End User, 2022
Figure 27 North America Melanoma Cancer Diagnostics Market: By End User, 2023-2030 (Usd Million)
Figure 28 North America Melanoma Cancer Diagnostics Market: By End User, Cagr (2023-2030)
Figure 29 North America Melanoma Cancer Diagnostics Market: By End User, Lifeline Curve
Figure 30 North America Melanoma Cancer Diagnostics Market: By Distribution Channel, 2022
Figure 31 North America Melanoma Cancer Diagnostics Market: By Distribution Channel, 2023-2030 (Usd Million)
Figure 32 North America Melanoma Cancer Diagnostics Market: By Distribution Channel, Cagr (2023-2030)
Figure 33 North America Melanoma Cancer Diagnostics Market: By Distribution Channel, Lifeline Curve
Figure 34 North America Melanoma Cancer Diagnostics Market: Snapshot (2022)
Figure 35 North America Melanoma Cancer Diagnostics Market: By Country (2022)
Figure 36 North America Melanoma Cancer Diagnostics Market: By Country (2023 & 2030)
Figure 37 North America Melanoma Cancer Diagnostics Market: By Country (2022 & 2030)
Figure 38 North America Melanoma Cancer Diagnostics Market: Product Type (2023-2030)
Figure 39 North America Melanoma Cancer Diagnostics Market: Company Share 2022 (%) 123

$3,500
$4,200

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings